Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.26 GBX | -0.41% | -1.11% | +38.25% |
Apr. 10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Apr. 10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
Sales 2023 | 3.1M 3.88M | Sales 2024 * | 9.52M 11.9M | Capitalization | 107M 133M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 22.3 x |
Net cash position 2023 | 7.71M 9.65M | Net cash position 2024 * | 2.94M 3.68M | EV / Sales 2024 * | 10.9 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 67.12% |
Latest transcript on Futura Medical plc
1 day | -0.41% | ||
1 week | -1.11% | ||
Current month | -12.95% | ||
1 month | -7.22% | ||
3 months | +16.35% | ||
6 months | +8.81% | ||
Current year | +38.25% |
Managers | Title | Age | Since |
---|---|---|---|
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Angela Hildreth
DFI | Director of Finance/CFO | - | 18-02-19 |
Ken James
CTO | Chief Tech/Sci/R&D Officer | - | 16-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Needham
CHM | Chairman | 68 | 21-10-07 |
Gordon Davis
BRD | Director/Board Member | 67 | Jan. 08 |
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 35.26 | -0.41% | 109 623 |
24-04-25 | 35.4 | -1.12% | 241,540 |
24-04-24 | 35.8 | +0.70% | 253,853 |
24-04-23 | 35.55 | -0.14% | 350,597 |
24-04-22 | 35.6 | -0.14% | 204,772 |
Delayed Quote London S.E., April 26, 2024 at 03:09 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.25% | 133M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-9.37% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- FUM Stock